SRF is a nuclear repressor of Smad3-mediated TGF-β signaling

Oncogene

Volumn 26, Issue 2, 2007, Pages 173-185

  Lee, H J ^a,b   Yun, C H ^a,c   Lim, S H ^a   Kim, B C ^a,d   Baik, K G ^a   Kim, J M ^a,f   Kim, W H ^e   Kim, S J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d Kangwon National University   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

^f Inha University School of Medicine   (South Korea)

Author keywords

Signaling; Smad; SRF; Suppression; TGF ; Transcription

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA; SERUM RESPONSE FACTOR; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; KIDNEY; LIVER NEOPLASMS; LUNG; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33846253532     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209774     Document Type: Article

References (51)

1. Abraham SE, Carter MC, Moran E. (1992). Mol Biol Cell 3: 655-665.
2. Alexandrow MG, Kawabata M, Aakre M, Moses HL. (1995). Proc Natl Acad Sci USA 92: 3239-3243.
3. Carcamo J, Zentella A, Massague J. (1995). Mol Cell Biol 15: 1573-1581.
4. Chai J, Tarnawski AS. (2002). J Physiol Pharmacol 53: 147-157.
5. Claassen GF, Hann SR. (2000). Proc Natl Acad Sci USA 97: 9498-9503.
6. Danielpour D, Sporn MB. (1990). J Biol Chem 265: 6973-6977.
7. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang X-F. (1995). Proc Natl Acad Sci USA 92: 5545-5549.
8. de Caestecker MP, Piek E, Roberts AB. (2000). J Natl Cancer Inst 92: 1388-1402.
9. Depoortere F, Pirson I, Bartek J, Dumont JE, Roger PP. (2000). Mol Biol Cell 11: 1061-1076.
10. Derynck R, Zhang Y, Feng XH. (1998). Cell 95: 737-740.
11. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM. (1993). Cell 74: 1009-1020.
12. Feng X-H, Lin X, Derynck R. (2000). EMBO J 19: 5178-5193.
13. Feng XH, Liang YY, Liang M, Zhai W, Lin X. (2002). Mol Cell 9: 133-143.
14. Garrigue-Antar L, Barbieux I, Lieubeau B, Boisteau O, Gregoire M. (1995). J Immunol Methods 186: 267-274.
15. Geng Y, Weinberg RA. (1993). Proc Natl Acad Sci USA 90: 10315-10319.
16. Hannon GJ, Beach D. (1994). Nature 371: 257-261.
17. Iavarone A, Massague J. (1997). Nature 387: 417-422.
18. Iyer D, Belaguli N, Fluck M, Rowan BG, Wei L, Weigel NL et al. (2003). Biochemistry 42: 7477-7486.
19. Iyer D, Chang D, Marx J, Wei L, Olson EN, Parmacek MS et al. (2006). Proc Natl Acad Sci USA 103: 4516-4521.
20. Janknecht R, Hipskind RA, Houthaeve T, Nordheim A, Stunnenberg HG. (1992). EMBO J 11: 1045-1054.
21. Johansen F, Prywes R. (1993). Mol Cell Biol 13: 4640-4647.
22. Kang SH, Bang YJ, Jong HS, Seo JY, Kim NK, Kim S-J. (1999). Br J Cancer 80: 1144-1149.
23. Kim BC, Lee HJ, Park SH, Lee SR, Karpova TS, McNally JG et al. (2004). Mol Cell Biol 24: 2251-2262.
24. Kim JH, Johansen FE, Robertson N, Catino JJ, Prywes R, Kumar CC. (1994). J Biol Chem 269: 13740-13743.
25. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J. (1990). Cell 62: 175-185.
26. Lee DK, Kim BC, Kim IY, Cho EA, Satterwhite DJ, Kim S-J. (2002). J Biol Chem 277: 38557-38564.
27. Lee HJ, Lee JK, Miyake S, Kim S-J. (2004). J Biol Chem 279: 2666-2672.
28. Mack CP, Owens GK. (1999). Circ Res 84: 852-861.
29. Lee MH, Yang HY. (2003). Cancer Metast Rev 22: 435-449.
30. Liu SH, Ma JT, Yueh AY, Lees-Miller SP, Anderson CW, Ng SY. (1993). J Biol Chem 268: 21147-21154.
31. Manak JR, Prywes R. (1991). Mol Cell Biol 11: 3652-3659.
32. Massague J, Chen YG. (2000). Genes Dev 14: 627-644.
33. Miano JM. (2003). J Mol Cell Cardiol 35: 577-593.
34. Moustakas A, Kardassis D. (1998). Proc Natl Acad Sci USA 95: 6733-6738.
35. Norman C, Runswick M, Pollock R, Treisman R. (1988). Cell 55: 989-1003.
36. Paradis P, MacLellan WR, Belaguli NS, Schwartz RJ, Schneider MD. (1996). J Biol Chem 271: 10827-10833.
37. Pardali K, Kurisaki A, Moren A, ten Dijke P, Kardassis D, Moustakas A. (2000). J Biol Chem 275: 29244-29256.
38. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM et al. (1994). Genes Dev 8: 9-22.
39. Psichari E, Balmain A, Plows D, Zoumpourlis V, Pintzas A. (2002). J Biol Chem 277: 29490-29495.
40. Rivera VM, Miranti CK, Misra RP, Ginty DD, Chen R-H, Blenis J et al. (1993). Mol Cell Biol 13: 6260-6273.
41. Qiu P, Feng X-H, Li L. (2003). J Mol Cell Cardiol 35: 1407-1420.
42. Schratt G, Weinhold B, Lundberg A, Schuck S, Berger J, Schwarz H et al. (2001). Mol Cell Biol 21: 2933-2943.
43. Shi Y, Massagué J. (2003). Cell 113: 685-700.
44. Sotiropoulos A, Gineitis D, Copeland J, Treisman R. (1999). Cell 98: 159-169.
45. Treisman R. (1992). Trends Biochem Sci 17: 423-426.
46. Treisman R. (1994). Curr Opin Genet Dev 4: 96-101.
47. Treisman R. (1995). EMBO J 14: 4905-4913.
48. Warner BJ, Blain SW, Seoane J, Massague J. (1999). Mol Cell Biol 19: 5913-5922.
49. Wrana JL, Attisano L. (2000). Cytokine Growth Factor Rev 11: 5-13.
50. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M et al. (1992). Cell 71: 1003-1014.
51. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B et al. (1998). Mol Cell 1: 611-617.